← Eichor
Study identifier: NCT06785532 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of RNS in Treatment-refractory Tourette's Syndrome

Condition: Tourette Syndrome  ·  Sponsor: Xuanwu Hospital, Beijing

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The study is to investigate the effect of personalized responsive neurostimulation (RNS) therapy guided by stereoelectroencephalography (SEEG) in patients with treatment-resistant Tourette's Syndrome (TR-TS).

This description comes directly from the study's public registry record.

Talk to the study team

Hongxing Wang, MD & PhD  ·  +861083198650  ·  wanghongxing@xwh.ccmu.edu.cn

Huang Wang, MD  ·  +861083198650  ·  wanghuang1118@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06785532